• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

FDA Clearance

AccurKardia’s AI-Powered ECG Software Earns FDA Breakthrough Device Designation for Aortic Stenosis Detection

by Syed Hamza Sohail 10/08/2024 Leave a Comment

AccurKardia's AI-Powered ECG Software Earns FDA Breakthrough Device Designation for Aortic Stenosis Detection

What You Should Know: -   AccurKardia, an innovator in ECG-based diagnostics technology, has announced that its Aortic Valve Stenosis (AVS) ECG-based AI screening software has been granted Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA). -  The company’s AVS screening software aims to leverage the ubiquity of the electrocardiogram (ECG) to identify potential cases of AVS within millions of ECGs already present in healthcare system electronic health records in
Read More

BioIntelliSense Optimizes Hospital Virtual Care with FDA-Cleared Rechargeable BioButton

by Fred Pennic 10/07/2024 Leave a Comment

BioIntelliSense Optimizes Hospital Virtual Care with FDA-Cleared Rechargeable BioButton

What You Should Know:  - BioIntelliSense, a leader in continuous health monitoring, has received FDA clearance for its rechargeable BioButton Multi-Patient wearable and BioDashboard system.  - The BioButton is poised to transform hospital virtual care programs by providing a cost-effective and scalable solution for continuous patient monitoring. Rechargeable and Reusable Wearable  The BioButton Multi-Patient wearable is a game-changer for inpatient settings. This
Read More

GE HealthCare Receives FDA Clearance for Innovative Alzheimer’s Imaging Tool

by Fred Pennic 10/04/2024 Leave a Comment

GE HealthCare Receives FDA Clearance for Innovative Alzheimer's Imaging Tool

What You Should Know:  - GE HealthCare announced today that its MIM Software has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for a groundbreaking tool in the fight against Alzheimer's disease.  - The advancement allows MIMneuro, a vendor-neutral software solution, to perform "Centiloid scaling" for analyzing and quantifying amyloid plaque density in the brain using positron emission tomography (PET) imaging. Impact of Alzheimer's
Read More

Withings Sleep Rx Receives FDA Clearance for Home Sleep Apnea Testing

by Jasmine Pennic 09/09/2024 Leave a Comment

Withings Sleep Rx Receives FDA Clearance for Home Sleep Apnea Testing

What You Should Know:  - Withings, a global leader in connected health, has announced that its Sleep Rx sleep apnea device has received clearance from the U.S. Food and Drug Administration (FDA).  - Sleep Rx represents a significant advancement in the diagnosis of sleep apnea, offering a more convenient and accurate alternative to traditional in-lab testing. Addressing the Underdiagnosis of Sleep Apnea Sleep apnea is a serious condition that affects millions of people
Read More

Qure.ai Receives FDA Clearance for AI-Powered Lung Nodule Analysis Tool

by Syed Hamza Sohail 08/23/2024 Leave a Comment

Qure.ai Receives FDA Clearance for AI-Powered Lung Nodule Analysis Tool

What You Should Know: - Qure.ai, a global innovator in medical imaging AI, has today announced a pivotal 510(k) FDA clearance for its AI-powered chest CT solution – qCT LN Quant. - The new AI solution is now available to support radiologists and pulmonologists in analyzing lung nodules on non-contrast chest CT scans and tracking volumetric growth as part of progression monitoring. Qure.ai Enhances Lung Cancer Care with AI-Powered qCT LN Quant Qure.ai has integrated qCT LN Quant into
Read More

AISAP’s AI-Powered Cardiac Ultrasound Receives FDA Clearance

by Jasmine Pennic 08/22/2024 Leave a Comment

FDA Clears First AI-assisted Point-of-Care Software for Structural Heart Disease and Heart Failure Diagnosis

What You Should Know:  - AISAP, a medical technology company specializing in AI-powered point-of-care assisted diagnosis (POCAD) solutions, announced today that it has received FDA 510(k) clearance for its groundbreaking CARDIO software platform.  - AISAP CARDIO is a cloud-based software package that combines four computer-assisted diagnosis (CADx) modules for valvular pathologies and eight key measurements into a single, user-friendly platform.  Point-of-Care
Read More

Diality Receives FDA Clearance for Innovative Hemodialysis System

by Fred Pennic 08/06/2024 Leave a Comment

Diality Receives FDA Clearance for Innovative Hemodialysis System

What You Should Know:  - Diality, a medical device company focused on advancing kidney care, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Moda-flx Hemodialysis System™.  - The Moda-flx Hemodialysis System is designed to enhance the dialysis experience for both patients and healthcare providers. With its variable flow rate ranges, integrated reverse osmosis water filtration, and user-friendly interface, clinicians
Read More

TytoCare Awarded FDA Clearance for AI Lung Sound Analysis

by Syed Hamza Sohail 07/31/2024 Leave a Comment

TytoCare Awarded FDA Clearance for AI Lung Sound Analysis

What You Should Know: -  TytoCare, a virtual care company enabling accessible, high-quality primary care from home, announced today that it has received an additional FDA clearance for a new AI-powered diagnostic capability, Tyto Insights for Crackle Detection. -       This capability, which is built on TytoCare’s database of lung sound recordings and driven by an innovative, AI-based algorithm, joins TytoCare’s existing suite of diagnostic tools, including
Read More

Philips IntelliSite Pathology Solution Receives 510(k) Clearance

by Fred Pennic 07/12/2024 Leave a Comment

Philips IntelliSite Pathology Solution Receives 510(k) Clearance

What You Should Know:  - Philips IntelliSite Pathology 5.1 has received 510(k) clearance from the FDA, solidifying its position as the most widely deployed digital pathology solution for primary diagnosis globally.  - With over 300 pathology labs already implementing Philips' solution, and over 20 labs achieving complete digital workflows, the success of this technology is evident. Investing in the Future of Cancer Care By empowering collaboration, boosting efficiency, and
Read More

FDA Clears AliveCor’s Heart Attack-Detecting AI Kardia 12L ECG System

by Fred Pennic 06/25/2024 Leave a Comment

AliveCor is pleased to share the dual FDA clearance and launch of the world’s first AI technology to detect 35 cardiac conditions (including heart attacks and afib) using a reduced leadset, KAI 12L, and the first AI-powered, pocket-sized 12-lead ECG System with a unique single-cable design, Kardia 12L.

What You Should Know:  - AliveCor, a leader in AI-powered cardiology, has received FDA clearance and launched a groundbreaking innovation – the Kardia™ 12L ECG System with KAI™ 12L AI technology.  - AliveCor's Kardia 12L ECG System signifies a major advancement in cardiac diagnostics. By combining cutting-edge AI technology with a portable and user-friendly design, the system empowers healthcare professionals to deliver faster, more accurate, and more accessible cardiac
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Interim pages omitted …
  • Go to page 10
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |